These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3128469)

  • 1. Clinical value of the guanase screening test in donor blood for prevention of posttransfusional non-A, non-B hepatitis.
    Ito S; Tsuji Y; Kitagawa N; Akihiko I; Syundo J; Tamura Y; Kishi S; Mori H
    Hepatology; 1988; 8(2):383-4. PubMed ID: 3128469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between guanase activity in donor blood and the incidence of posttransfusional non-A, non-B hepatitis, and a possible method for preventing posttransfusional hepatitis.
    Ito S; Tsuji Y; Iwasaki A; Kitagawa N; Tamura Y; Fujii S
    Hepatology; 1986; 6(5):990-3. PubMed ID: 3093359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of posttransfusional non-A, non-B hepatitis using the screening test for guanase activity of donor blood.
    Ito S; Tsuji Y
    Gastroenterol Jpn; 1988 Apr; 23(2):153-9. PubMed ID: 3133278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanase activity in the donor serum and the incidence of posttransfusion hepatitis non-A, non-B.
    Nakahara M; Takanara M; Yamauchi M; Fujisawa K; Kameda H
    Ann Acad Med Singap; 1986 Apr; 15(2):215-20. PubMed ID: 3092723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of serum guanase activity and prevention of non-A, non-B hepatitis].
    Yamasaki S; Egashira S; Koga M; Akagawa H
    Nihon Rinsho; 1984 Mar; 42(3):740-53. PubMed ID: 6433080
    [No Abstract]   [Full Text] [Related]  

  • 6. [The relationship between the guanase activity of donor and incidence of posttransfusion hepatitis].
    Ito S
    Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):337. PubMed ID: 3923236
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prevention of post-transfusional hepatitis using measurement of guanase activity].
    Ito S
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2266. PubMed ID: 3820751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening of the donor's blood by measuring the serum guanase level for the prevention of posttransfusion hepatitis in cardiac surgery].
    Akagawa H; Isomura T; Koga M; Egashira S; Yamasaki S; Ueki K; Suenaga R
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Jun; 32(6):932-7. PubMed ID: 6491407
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of posttransfusional non-A, non-B hepatitis by a screening test for hepatitis C virus antibody of donor bloods.
    Ito S; Takaoka T; Kajimoto Y; Muguruma N; Fukuda T; Okabe T; Horikita M; Hibino S; Hayashi H; Honda H
    Tokushima J Exp Med; 1991 Jun; 38(1-2):19-23. PubMed ID: 1719660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum guanase activity in various liver diseases.
    Shiota G; Fukada J; Ito T; Tsukizawa M; Yamada M; Sato M
    Jpn J Med; 1989; 28(1):22-4. PubMed ID: 2542677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of serum guanase in alcoholic liver disease.
    Ito S; Xu YH; Keyser AJ; Peters RL
    Tokushima J Exp Med; 1984 Jun; 31(1-2):1-7. PubMed ID: 6528340
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of serum guanase activity in liver diseases.
    Nishikawa Y; Fukumoto K; Watanabe F
    Clin Biochem; 1984 Oct; 17(5):327-30. PubMed ID: 6499163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum guanase activities after myocardial infarction.
    Ellis G; Goldberg DM
    Clin Chim Acta; 1975 Sep; 63(2):205-10. PubMed ID: 1175293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of guanase in serum and liver function tests in HBe antigen-positive chronic hepatitis].
    Nishikawa Y; Fukumoto K; Watanabe F; Yoshihara H
    Rinsho Byori; 1989 Dec; 37(12):1392-4. PubMed ID: 2614968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of guanase analysis in biochemical laboratory tests].
    Ito S
    Nihon Rinsho; 1989 Dec; 48 Suppl():264-6. PubMed ID: 2621882
    [No Abstract]   [Full Text] [Related]  

  • 16. A simple and sensitive radiochemical assay for plasma guanase.
    van Bennekom CA; van Laarhoven JP; de Bruyn CH; Oei TL
    J Clin Chem Clin Biochem; 1978 Apr; 16(4):245-8. PubMed ID: 641452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of measurement of serum guanase activity as a screening test of liver damage.
    Ito S; Takaoka T; Hirano H; Kishi S; Mori H
    Gastroenterol Jpn; 1981; 16(5):478-92. PubMed ID: 7327386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate testing for non-A, non-B hepatitis.
    Anderson CC; Contreras M; Barbara JA; Mijovic V
    Lancet; 1987 Apr; 1(8538):912. PubMed ID: 2882303
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing the incidence of non-A,non-B post-transfusion hepatitis by testing donor blood for alanine aminotransferase: economic considerations.
    Hornbrook MC; Dodd RY; Jacobs P; Friedman LI; Sherman KE
    N Engl J Med; 1982 Nov; 307(21):1315-21. PubMed ID: 6813736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of non-A non-B hepatitis in Guadeloupe].
    Fest T; Gordien E; Neubauer J; Citadelle E; Agis F
    Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):483-4. PubMed ID: 2517013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.